We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cPass

News List

GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit prnasia
July 29, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application covering a novel Surrogate Virus Neutralization Test (sVNT).
Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test prnasia
June 22, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).
GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore prnasia
April 12, 2021
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway's panel of specialist and GP clinics.
Duke, GenScript, A*STAR Enter COVID-19 Pact contractpharma
May 19, 2020
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimen.